Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 29,747 | reported | 03 Jun 2025 | tx 6+119,032 |
| EXELIXIS, INC. | 28,957 | reported | 27 May 2026 | tx 33+487,724−392,656 |
| AXONYX INC | 0 | reported | 25 Oct 2016 | tx 13+1,164,789−715,533 |
| Audentes Therapeutics, Inc. | 0 | reported | 15 Jan 2020 | tx 8+53,200−53,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | EXELIXIS, INC. | 8,367 | 0.00 USD | |
| 18 Feb 2026 | EXERCISE | EXELIXIS, INC. | 20,030 | 21.69 USD | |
| 18 Feb 2026 | SALE | EXELIXIS, INC. | 44,087 | 44.50 USD | |
| 18 Feb 2026 | EXERCISE | EXELIXIS, INC. | 44,087 | 19.39 USD | |
| 17 Feb 2026 | SALE | EXELIXIS, INC. | 42,422 | 43.33 USD | |
| 18 Feb 2026 | SALE | EXELIXIS, INC. | 20,030 | 44.30 USD | |
| 17 Feb 2026 | EXERCISE | EXELIXIS, INC. | 42,422 | 18.19 USD | |
| 17 Feb 2026 | EXERCISE | EXELIXIS, INC. | 42,422 | 0.00 USD | deriv |
| 18 Feb 2026 | EXERCISE | EXELIXIS, INC. | 20,030 | 0.00 USD | deriv |
| 18 Feb 2026 | EXERCISE | EXELIXIS, INC. | 44,087 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 29,747 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | EXELIXIS, INC. | 9,812 | 0.00 USD | |
| 27 Feb 2025 | SALE | EXELIXIS, INC. | 54,514 | 38.13 USD | |
| 28 Feb 2025 | EXERCISE | EXELIXIS, INC. | 19,294 | 19.77 USD | |
| 28 Feb 2025 | SALE | EXELIXIS, INC. | 19,294 | 37.62 USD | |
| 27 Feb 2025 | EXERCISE | EXELIXIS, INC. | 31,167 | 20.50 USD | |
| 27 Feb 2025 | EXERCISE | EXELIXIS, INC. | 23,347 | 19.77 USD | |
| 27 Feb 2025 | EXERCISE | EXELIXIS, INC. | 31,167 | 0.00 USD | deriv |
| 28 Feb 2025 | EXERCISE | EXELIXIS, INC. | 19,294 | 0.00 USD | deriv |
| 27 Feb 2025 | EXERCISE | EXELIXIS, INC. | 23,347 | 0.00 USD | deriv |
| 13 Aug 2024 | OTHER | EXELIXIS, INC. | 4,682 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 7,639 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | EXELIXIS, INC. | 10,015 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | EXELIXIS, INC. | 20,030 | 0.00 USD | deriv |
| 21 May 2024 | SALE | EXELIXIS, INC. | 27,280 | 21.12 USD |